{
  "id": 140283,
  "title": "Merck plans trial of sac-TMT combo with Keytruda in lung cancer",
  "url": "https://urgent.news/2026/08/04/merck-plans-trial-of-sac-tmt-combo-with-keytruda-in-lung-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-04T17:30:31.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/merck-plans-trial-of-sac-tmt-combo-with-keytruda-in-lung-cancer/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Merck provided some of the clearest direction yet regarding its ambitions in oncology to improve on its blockbuster immunotherapy Keytruda. The company plans to conduct a trial testing its experimental antibody-drug conjugate sac-TMT in combination ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}